S100A8 and central nervous system cancer: Although S100A8 had been shown to be involved in augmenting the malignant biological progression of glioma, such as proliferation, invasion, and migration, there was no specific research referring to the role of S100A8 in regulating MES phenotype transition of GSCs [48, 49].